|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164 TWD | 0.00% |
|
+8.25% | -15.68% |
| 05-23 | Oneness Biotech Co., Ltd. Provides Update on Bonvadis Wounds Management Medical Device | CI |
| 05-21 | Oneness Biotech Co., Ltd. Announce Chairperson Changes | CI |
Oneness Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 25.81 million compared to TWD 22.19 million a year ago. Net loss was TWD 92.62 million compared to TWD 264.68 million a year ago.
Basic loss per share from continuing operations was TWD 0.2 compared to TWD 0.59 a year ago. Diluted loss per share from continuing operations was TWD 0.2 compared to TWD 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.68% | 2.29B | |
| +56.73% | 815B | |
| +43.90% | 641B | |
| -6.86% | 352B | |
| +17.60% | 314B | |
| +10.25% | 303B | |
| +16.08% | 242B | |
| +2.29% | 224B | |
| +13.96% | 218B | |
| +8.32% | 168B |
ONENESS BIOTECH CO., LTD. 
